Eli Lilly and Company (LLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2000 | 12-1999 | 12-1998 | 12-1997 | 12-1996 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 3,057,800 | 2,721,000 | 2,097,900 | -385,100 | 1,523,500 |
| Depreciation Amortization | 435,800 | 439,700 | 490,400 | 509,800 | 543,500 |
| Income taxes - deferred | -442,700 | N/A | N/A | N/A | N/A |
| Accounts receivable | -165,400 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 1,143,800 | N/A | N/A | N/A | N/A |
| Other Working Capital | 777,700 | -425,800 | 134,500 | 442,600 | -185,100 |
| Other Operating Activity | -1,075,500 | -115,200 | -93,000 | 1,833,100 | 109,500 |
| Operating Cash Flow | $3,731,500 | $2,619,700 | $2,629,800 | $2,400,400 | $1,991,400 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -337,700 | N/A | N/A | N/A | N/A |
| PPE Investments | -672,800 | -450,000 | -389,300 | -354,800 | -432,700 |
| Net Acquisitions | N/A | 1,600,000 | 0 | 0 | -97,100 |
| Purchase Of Investment | -714,700 | N/A | N/A | N/A | N/A |
| Sale Of Investment | 803,100 | N/A | N/A | N/A | N/A |
| Other Investing Activity | -134,400 | -63,300 | 95,400 | 1,164,500 | 61,800 |
| Investing Cash Flow | $-1,056,500 | $1,086,700 | $-293,900 | $809,700 | $-468,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -203,000 | N/A | N/A | N/A | N/A |
| Debt Issued | 1,100 | N/A | N/A | N/A | N/A |
| Debt Repayment | -27,200 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 178,400 | N/A | N/A | N/A | N/A |
| Common Stock Repurchased | -1,052,800 | N/A | N/A | N/A | N/A |
| Dividend Paid | -1,126,000 | -1,000,500 | -877,700 | -818,000 | -753,200 |
| Other Financing Activity | 0 | -452,200 | -1,935,000 | -1,136,600 | -907,900 |
| Financing Cash Flow | $-2,229,500 | $-1,452,700 | $-2,812,700 | $-1,954,600 | $-1,661,100 |
| Exchange Rate Effect | -31,000 | -49,000 | 25,000 | -121,700 | -48,100 |
| Beginning Cash Position | 3,700,400 | 1,495,700 | 1,947,500 | 813,700 | 999,500 |
| End Cash Position | 4,114,900 | 3,700,400 | 1,495,700 | 1,947,500 | 813,700 |
| Net Cash Flow | $414,500 | $2,204,700 | $-451,800 | $1,133,800 | $-185,800 |
| Free Cash Flow | |||||
| Operating Cash Flow | 3,731,500 | 2,619,700 | 2,629,800 | 2,400,400 | 1,991,400 |
| Capital Expenditure | -677,900 | N/A | N/A | N/A | N/A |
| Free Cash Flow | 3,053,600 | 2,619,700 | 2,629,800 | 2,400,400 | 1,991,400 |